Skip to main content
MEDICOX Co., Ltd. logo

MEDICOX Co., Ltd. — Investor Relations & Filings

Ticker · 054180 ISIN · KR7054180005 KO Manufacturing
Filings indexed 803 across all filing types
Latest filing 2022-11-17 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 054180

About MEDICOX Co., Ltd.

https://www.medicox.co.kr

MEDICOX Co., Ltd., formerly ChoongAng Ocean Co Ltd, is a company engaged in the manufacture and sale of shipbuilding materials and equipment. Its primary products are structural components for large vessels, including curved blocks, bow and stern sections, propeller bosses, and engine room parts. In addition to its core shipbuilding business, the company is diversifying into the biopharmaceutical sector, focusing on new drug development and the commercialization of pharmaceutical products.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) for the company Medicox. It details the amendment of share counts, issuance prices, and the purpose of capital raising. This type of regulatory filing concerning capital structure changes and share issuance falls under the 'Share Issue/Capital Change' category.
2022-11-17 Korean
[기재정정]주요사항보고서(무상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주요사항보고서(무상증자결정)' which translates to 'Report on Material Matters (Decision on Bonus Issue/Free Capital Increase)'. It details a correction (정정신고) to a previous announcement regarding a bonus share issuance (무상증자). Since this document describes a change in capital structure through a bonus issue of shares, it falls under the category of Share Issue/Capital Change.
2022-11-15 Korean
권리락(무상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short announcement regarding a 'rights off' (권리락) event due to a bonus issue (무상증자) for the company Medicox. This type of corporate action announcement regarding capital changes fits the definition of a share issue or capital change announcement.
2022-11-15 Korean
투자판단관련주요경영사항(경구용 인슐린 캡슐 (ORMD-0801)의 국내 유통 라이선스 계약 체결)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Medicox) regarding a material business event, specifically the signing of a licensing agreement for the distribution of an oral insulin capsule. In the context of Korean corporate filings (DART system), '투자판단 관련 주요경영사항' (Major Management Matters related to Investment Decisions) is a standard regulatory disclosure category for significant business contracts, partnerships, or licensing deals. Since it does not fit into specific categories like M&A (which usually implies corporate control changes) or other specialized categories, it is best classified as a general Regulatory Filing (RNS).
2022-11-14 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 메디콕스' covering the period from January 1, 2022, to September 30, 2022. It contains detailed corporate information, financial data, and management disclosures required for a quarterly filing. Based on the content and the definition provided, this is an Interim/Quarterly Report. 9M 2022
2022-11-14 Korean
파생상품거래손실발생
Capital/Financing Update Classification · 100% confidence The document is a regulatory disclosure from Medicox regarding a 'Loss from Derivative Transactions' (파생상품거래손실발생). It details the financial impact of derivative valuation losses related to convertible bonds, specifically citing K-IFRS accounting standards. Since this is a specific regulatory disclosure of a material financial event that does not fit into standard periodic reports, dividend notices, or management changes, it falls under the general regulatory filing category.
2022-11-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.